Richard I. Steinhart, CFO: BioXcel Therapeutics BTAIQ Sell · Filed 24/06/18

Trade details

Type: Insider sale
Amount: $468.72
Shares · price: 372 sh · $1.26 a share
Held after: 5,476 sh
Stock: BioXcel Therapeutics BTAIQ
Person: Richard I. SteinhartCFO
Trade date: 24/06/17
Filed: 24/06/18
Days to filing: 1 days

Sold 6.4% of holdings

Share of holding sold: 6.4%

BioXcel Therapeutics trades, last 26 weeks

What else happened in BioXcel Therapeutics around then

Filed or reported within 30 days of the trade day · 24/05/18~24/07/17

Richard I. Steinhart's recent trades

Richard I. SteinhartCFO
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$7,461
6,845 sh
$7,461
Filed 05/22
Traded 05/20
Richard I. SteinhartCFO
Planned sale10b5-1 planBioXcel Therapeutics
Planned sale10b5-1 plan
BioXcel Therapeutics
BTAIQ
$7,426
6,845 sh
$7,426
Filed 05/20
Traded 05/20
Richard I. SteinhartCFO
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$74
205 sh
$74
Filed 24/12/17
Traded 24/12/16
Richard I. SteinhartCFO
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$134
372 sh
$134
Filed 24/12/17
Traded 24/12/16
Richard I. SteinhartCFO
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$3,946
7,175 sh
$3,946
Filed 24/10/03
Traded 24/10/03

Richard I. Steinhart, CFO — sold $469 of BioXcel Therapeutics BTAIQ · 6.4% of holdings · 10b5-1 plan | Whalegun